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ABSTRACT

This work examines consumer awareness of soy, including which information source enabled
consumers to form their beliefs regarding soy's health implications. Controversy surrounds
the much-researched topic of soy, including its isolated compounds, processing and
manufacturing methods, seed source, and consumption amounts. Inconsistent results in
research lead to disagreements on what is and what is not safe, and for whom. Participants in
six states were recruited from a convenience sample and asked to complete a seven-question
survey. Results indicate a great amount of uncertainty with consumers regarding whether soy
is beneficial or detrimental, especially when considering the prevalence of internet soy fear
mongering. In order for consumers to feel confident in consuming soy foods and sharing
them with their families, future studies must resolve questions surrounding genetically
modified organisms (GMO) and hexane processed soy and arm consumers and educators
with recent and reliable soy health information.
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Chapter 1: Overview of Study
Introduction – Statement of Problem
With more than 2,000 peer-reviewed journal articles published each year relating to
soy, health professionals have volumes of credible information to stay continuously updated.
However, the controversy over soy and disease leaves some health practitioners and
consumers uneasy. Unanswered questions surround research, such as is lifetime exposure a
key factor (1) as to why soy's phytoestrogens can act as an estrogen antagonist or agonist (2),
or is it the fact that some people are equol producers (3) and some aren't? Some research
states that the protective effects of soy are only realized while consuming whole soy foods
(4), yet other studies assert it is the isoflavone that is protective (5). Additional studies
maintain that fermented is more protective than nonfermented soy (6). Some researchers use
the same amounts of soy in their research as Asians traditionally consume in their everyday
diet, while others employ amounts of soy protein or isolates in their research that are
impossible to achieve through daily dietary measures (3). The confounding results of recent
studies create polarizing views regarding soy's role in regard to cancer, heart disease, weight
management, thyroid health, and fertility.
Questions also arise as to the quality of the soy and its bioactive constituents that is
being used in research, as well as whether soy's protective effect occurs only in
premenopausal versus postmenopausal women, or vice versa. In addition, over the past two
years the safety of genetically modified soy and soy processed with hexane has been brought
to consumers' attention. Other major concerns today relate to whether soy is safe for infants,
children, and breast cancer survivors.

Questioning the safety of soy first occurred to the author when her daughter needed to
supplement breast milk for her then 10-month-old daughter. Being from a family with
notorious dairy allergies, the author researched the possibility of the mother using organic
soy infant formula and was satisfied the infant would clearly derive health benefits over cow
milk-based formula. However, the intensity of the controversy over soy was brought to the
author's attention following an incident her daughter experienced with a stranger upon
leaving a health food store after buying organic soy infant formula. The woman followed her
through the parking lot claiming she was killing her child by feeding her soy formula,
demanding that she return the formula, and labeling her an unfit mother if she didn't.
Other instances brought soy's controversy to the author's attention when clients
became adamant about soy's dangers after soymilk or tofu was mentioned as a high-quality
protein in a nutritional consultation. Furthermore, while teaching across the United States,
the author has seen followers of the Weston A. Price Foundation become agitated, shout out,
and even storm away from a meeting if soy is mentioned as having health benefits.
Soybeans have been a staple food for the Chinese for more than 5,000 years, and its
use as a high-quality protein food slowly spread across Korea, Japan, India, Europe and
America (7). The low incidences of prostate and breast cancer in China, fueled by the low
rates of heart disease in Japan, piqued interest in the 1990s when researchers began to
consider the idea that soy and its constituents held properties for preventing chronic disease
(8). Around the same time, the United States National Cancer Institute sponsored research
on soy, and results indicated that soy possessed an ability to lower cholesterol, inhibit bone
loss, and reduce hot flashes (9).
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Significance and Purpose of Study
This research is significant to the discipline of nutrition. Nutritionists are educators,
and educators must convey accurate and timely information on soy to clear away any
misconceptions among patients and the public. Therefore, this thesis examines the
consumers' awareness of soy, including which information source was referenced to enable
one to form a personal belief regarding the safety of soy. The author's hope is that, from the
results of this study, nutritionists, clinicians, health professionals, and educators will
• receive access to accurate and up-to-date information on the latest soy research,
• gain a better understanding of what patients and consumers believe about soy, and
• learn whether their sources for information are credible.
The greater goal is to help the public make the best choice possible for their long-term health.
Voluntary participants in this study were procured from a convenience sample of
individuals from across the country who attended day-long seminars on herbal medicine and
nutrition between August 26 and November 4, 2011. Participants included a small number of
health professionals; however, the vast majority had never before attended a health class.
Participants were asked to complete a seven-question survey.
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Chapter 2: Review of Literature
History of Soy Research
The scientific community has been researching soy since the 1940s when attention
was drawn to infertility issues in sheep grazing on red clover. It wasn't until the 1950s that
researchers discovered that the estrogenic isoflavones in soy could function as both an antiestrogen and a growth promoter for the animal feed industry. In 1995 soy protein studies
indicated that these estrogenic isoflavones could be an alternative to conventional hormone
replacement therapy (9) and research on soy exploded, with a focus on Asians and their soy
consumption patterns.
In 1999 the United Nations Food and Agriculture Organization (FAO) recorded that
North Koreans consumed up to 9.6 grams of soy per day, followed by the Japanese (8.7 gr),
Indonesians (7.4 gr), South Koreans (6.5 gr), and Chinese (5.1 gr). Just four years later, in
2003, the FAO recorded that Chinese consumption had dropped to 3.4 grams per capita,
while all other nations either increased their soy consumption slightly or remained the same.
Europeans and Americans ate <1 gram of soy protein per day consistently (10). Interestingly,
the incidence of breast cancer continued to increase in the East Asian countries of China,
Japan, and Korea, as their dietary habits changed and they began to adopt a Western diet
(11). Ordinarily prone to stomach, esophageal, and liver cancer, when Chinese adopted a
Western diet they became susceptible to heart attacks and other cancers as well (12).
Results for the connection between cancer and soy food consumption have been
inconsistent when comparing U.S. and Asian-based cohorts. Reasons include differing
amounts of long-term consumption and types of soy foods ingested (12). Research is linking
high soy intake early in life with reduced risk of premenopausal breast cancer later in life;
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and while Asians consume soy over their lifetime, Westerners may not begin ingesting soy
until adulthood (13).
Consumption Patterns
A recent article in the Journal of the American Medical Association suggests 10% or
more of Asian's daily protein intake comes from soy, with an average intake of isoflavones at
45-50 mg/d, compared to <1-6 mg/d of isoflavones in Western populations (14,15). Some
researchers calculate that Asian diets contain levels of 10-25 mg of isoflavones per day (16),
with the mean dietary intake of soy foods in Chinese women being approximately 7.36 gr/d
(12). Studies show that up to 50 mg of isoflavones daily has little impact on circulating
hormone levels although >100 mg can reduce the functioning of the ovaries, and 150 mg can
significantly increase the occurrence of endometrial hyperplasia in non-Asian women (16).
The Asian diet is highlighted by fermented soy foods, such as miso, natto, sufu,
tempeh, douchi, and soy sauce (12). According to an article published in Cancer Science
earlier this year, researchers conducted a study on gastric cancer patients where results
demonstrated that consuming fermented soy foods was significantly associated with an
increased risk, whereas nonfermented soy decreased the risk. This could explain the reason
for the high incidence of gastric cancer in the Korean and Japanese populations due to their
high intake of fermented foods (6).
In a prostate cancer study published last year in Urology, chemoprotective properties
were significantly observed with a reduction in risk in Asian men when nonfermented soy
was used, yet fermented soy did not have the same effect. However, soy had no effect on the
prostate-specific antigen (PSA) levels of Western men or those already possessing healthy
prostates whether fermented or nonfermented soy was used (5).
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In the United States, tofu and soy protein isolates are substituted for animal meats
(12). Asian soy consumers focus on whole soy foods such as edamame, cooked soybeans,
and soy milk, whereas American soy consumers focus on soy supplements (15) and
processed foods containing defatted soy protein in the form of frozen soy desserts, soy infant
formula, and soy cheese (10). In addition, Americans enjoy meat substitutes processed with
added soy compounds or soy protein isolates (15). Meat substitutes made from soy were
developed by scientists employed by Henry Ford during the Great Depression and come in
the form of vegetarian chicken, sausage, steaks, lunchmeats, burgers, hot dogs, and bacon
bits. Other uses of whole or defatted soy protein can be found extending meat in schools,
enhancing cereals and energy bars, and as a base in protein-fortified weight loss drinks (10).
However, the United States Food and Drug Administration's (FDA) claim that "25 grams of
soy protein a day, as part of a diet low in saturated fat and cholesterol, may reduce the risk of
heart disease" does not extend to isolated soy components (12).
Soy Isoflavones
Isoflavones are abundant in soy products, and their distribution and content can
greatly vary in different parts of the soybean. The three types of isoflavones that are abundant
in soy, in order of proportion, are genistein (50-55% of the total isoflavone content in soy),
daidzein (40-45%), and glycitein (5-10%) (3,17). Isoflavones exist in soy in the form of
aglycones. These isoflavone types are present in three chemical forms: acetylglucosides,
malonylglucosides, and the glucosides genistin, daidzin, and glycitin (14,18). The germ coat
is high in glycitin and daidzin while the cotyledon, which forms the leaf, contains the largest
amount of genistin and daidzin. The germ holds the greatest amount of the antioxidant value
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in the soybean seed (19). Depending on the manufacturing process, the content of
isoflavones can range from .3 mg to 5.5 mg per gram of protein (14).
Isoflavones structurally resemble estrogen (5) and can bind to estrogen receptor sites,
thereby inhibiting the action and biological availability of natural estrogen. Further,
isoflavones can reduce the body's estrogen production and increase clearance from
circulation (14) to inhibit the growth of estrogen-dependent cancer cells (2,13,20). The
isoflavone genistein has a greater affinity for beta cells than alpha cells by 7-30 fold (3) and
can act as an estradiol in target tissues (21). Genistein has been shown to inhibit cell growth
in prostate cancer (5).
Phytoestrogens are thousands of times less potent than endogenous estrogen (2), and
even the potency of xenobiotic estrogens is low in comparison to endogenous estrogen (3).
The structure of these plant estrogens allows them to bind to both beta and alpha-receptor
sites, and, depending on the level of biologically produced estrogen, phytoestrogens can act
as an estrogen antagonist or agonist (2).
In the peer-reviewed journal, Nutrition for the Family, author K. H. Morin reports
that research surrounding soy's estrogenic effect on males regarding fertility and feminization
indicates that neither soy foods nor supplements negatively affect reproductive health or
testosterone levels (22). Nor does it appear that soy protein isolates adversely affect semen
volume, count, motility, or concentration (23). In addition, reports indicate that soy protein
substantially lowers the risk of ovulatory infertility in women (22) along with endometrial
and ovarian cancers (24).
A study published by the American Journal of Clinical Nutrition in 2010 questioned
whether the protective effect of soy on breast cancer in Asian populations was due to isolated
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soy isoflavones, a combination of soy isoflavones, or a combination of soy and other dietary
factors (25) such as their high consumption of fruits and vegetables (12). Inconsistent results
in studies targeting isolated soy components or processed soy foods have researchers
believing their focus should be on traditional whole soy foods (4).
The Australian Journal of Herbal Medicine published a study in 2011 indicating that
when isoflavones were combined, they did not affect tumor growth; however, diadzein alone
increased lung and heart metastases and increased mammary tumors by 38%, while genistein
alone was able to decrease bone and liver metastases, as well as decrease mammary tumors
by 33% (3,26). A recent study conducted on soy and reported in the Journal of Integrative
Biology indicated that soy extract hastened apoptosis in in-vitro studies more significantly
than genistein or daidzein alone, suggesting that whole soy foods are more tumor cellspecific and chemoprotective than isolated compounds (27).
Animal Studies with Soy
An animal study published in 2009 in the International Journal of Biotechnology and
Biochemstry demonstrates that soy-enriched pet food does not negatively affect hormone
levels in animals (18), while other studies reported in the Society of Gynecologic Nurse
Oncologists journal reveal an increase in breast tumor growth when refined soy products are
fed to animals (2). In mice implanted with tumors, inconsistent outcomes suggest the results
depend upon the isoflavone preparation used as reported last year in Nutrition Review (14).
The results of animal studies remain questionable in their relevance to humans due to
the use of parenteral doses of purified isoflavones that are 8 to 16 times greater than that
found in the typical Asian diet. Additionally, it is speculated that 95% of the isoflavones in
humans are essentially inactive; and while the diadzein metabolite equol prevails in rodents,
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only 30-50% of humans are equol producers (3). Equol binds more easily to estrogen
receptors than does its precursor daidzein (28).
Body Composition and Weight
According to BMC Neuroscience, parenteral equol in animal studies conducted in
2011 demonstrated a significant decrease in body weight, white adipose fat tissue, and
depressive-related behavior (29). Human studies find a mildly favorable effect on body
composition in postmenopausal women when 15 gr of soy protein or 100 mg of soy
isoflavones daily were consumed over a six-month period (30). A study with menopausal
women showed a 7.5% reduction in total abdominal fat and a 9.1% decrease in subcutaneous
abdominal fat when 20 grams of soy protein and 160 milligrams of isoflavones were
consumed daily. A decrease in interleukin was also realized (20).
A 2011 study of healthy, obese, menopausal women published in Phytomedicine
indicated that, after six months of treatment with a daily isoflavone extract consisting of 80
mg of genistein, 16 mg of daidzein, and 3.2 mg of glycitein, a decline in both TNF-alpha and
serum leptin was observed, along with an increase in adiponectin levels (31). A different
study suggested that a high soy protein breakfast was deemed more satiating than a normal
soy protein breakfast, and people who ate 47 gr of soy protein daily lost weight as well as
lowered their low-density lipoprotein (32).
Cardiovascular Health
Lipid effect has not been well established for soy-based products (33), causing the
FDA to reevaluate the cardiovascular health benefit statement for soy (34). For example, one
four-week study failed to show a significant effect in cholesterol levels when subjects
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consumed three 16-ounce servings of vanilla soymilk daily (35), whereas another study
found that after just three weeks there was a 20% increase in high-density lipoprotein (HDL)
in subjects consuming soymilk (33); and four separate trials disclosed beneficial effects on
arterial stiffness with the intake of soy and soy isoflavones (36).
In a longitudinal study published in 2008 in Diabetes Care, cardiovascular risks
including LDL, total cholesterol, and serum triglyceride levels were significantly affected by
soy consumption, and C-reactive protein levels decreased considerably (37). A second study
reported in the Indian Journal of Clinical Biochemistry evaluated the cardiovascular effects
of soy protein and isoflavone consumption in postmenopausal women. The group
consuming 30 gr/d of soy protein had a highly significant improvement in Apolipoprotein A1
and B, as well as in their lipid profile, while women taking 60 milligrams of soy isoflavones
daily exhibited significant improvement in triglyceride levels (38).
Bone Mass Density
Bone mass density effect has also not been well established for soy. While traditional
soy foods significantly affect fracture protection and bone mineral density in Asians, using
isolated soy protein in Western intervention studies produces inconsistent results. Higher
concentrations of isoflavones than are associated with the traditional Asian diet do not yield
the same evidence as whole soy's positive effect on bones (39). However, while there is
increased urinary calcium excretion associated with animal protein, there is not with soy
protein (40).
As published in the American Journal of Clinical Nutrition in 2010, the results of a
three-year trial involving menopausal women demonstrated that soy isoflavones had only a
modest effect on bones and just at the femoral neck (41). A gender-specific study in
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Singapore demonstrated a reduction in hip fracture risk between 21%-36% in women with
dietary intakes of <49.4 gr/d of tofu, <2.7 gr of soy protein, and <5.8 mg of isoflavones,
although this reduction did not occur in men (42) nor did it occur in two other studies
involving Western men (43).
A two-year study involving healthy menopausal women evaluated soy
supplementation through daily ingestion of supplements made from the stem of germinating
soy seedlings (hypocotyl). And although whole-body bone loss was reduced at a dose of 120
mg/d, at common fracture sites there was no slowing of bone loss. At the same time results
indicated all blood chemistry remained within normal range, no differences were observed in
endometrial thickness or uterine fibroids, and the supplement did not affect free thyroxine
levels, as reported by the American Journal of Clinical Nutrition in 2009 (44).
Thyroid Health
Genistein and daidzein have been identified as thyroid inhibitors (12). A
retrospective study concluded that teens fed soy formula as infants demonstrated twice the
prevalence of autoimmune thyroid diseases of the control group or healthy siblings (45);
however, soy products can produce insignificant effects on thyroid function in healthy adults
(46). A 2010 study demonstrated negligible affects on thyroid function when
postmenopausal women consumed soy isoflavones for 3 years; yet an earlier 6-month study,
also with postmenopausal women, indicated that half the subjects developed hypothyroid
symptoms or goiter when consuming 30 gr of soybeans daily. Interestingly, symptoms of
hypothyroidism ceased after discontinuing soy for just one month (45).
Studies conducted decades ago revealed that infants consuming soy-based formula
without iodine were capable of developing goiter and hypothyroidism. It has been suggested
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since that time that those with autoimmune thyroid diseases, hypothyroidism, and iodine
deficiencies should avoid soy (45). Dr. Jorge Flechas, the foremost authority on iodine in the
world, believes nearly 12% of the population to be iodine deficient and therefore
recommends a simple 24-hour iodine load test to determine individual deficiencies (47). A
useful analysis, this test requires the ingestion of 50 mg of iodine and a complete collection
of urine for 24 hours. The idea behind this test is that when the body has attained maximal
retention of iodine, urinary excretion increases. The excretion is measured and calculated to
represent the level of iodine available in the body. Based on this calculation, the amount of
iodine supplementation is determined for an individual. Both medical professionals and
laypersons have access to these tests for a reasonable fee (48).
While the average American diet contains approximately 167 mcg of iodine daily, the
Japanese diet contains significant levels of dietary iodine including 7,000 mcg daily from just
kombu alone. The Japanese diet can vary from 5280 to 13,800 mcg of iodine daily and
thereby exceed the upper safety limit of 1 mg by up to an average of 5-25 times. However,
these levels do not appear to negatively affect thyroid function in normal Japanese
individuals. Although studies show that an excessive intake of iodine can cause thyroid
nodules, autoimmune thyroid disease, or hyperthyroidism, the Japanese instead demonstrate
a protective affect towards both benign and malignant breast disease, and a lower incidence
of cancers of the ovary, endometrium, and prostate (49). In fact, iodine has been shown to
effectively treat fibrocystic breast disease at doses of 3-6 mg daily (50). Perhaps the reason
for the positive effect soy demonstrates in protecting Asians from breast cancer is the fact
that they have a diet higher in iodine, which offsets the goiterogenic effects of soy.

12

Soy proteins and isoflavones may affect serum T3 and/or T4 in humans and animals,
and yet there remains inconsistent findings in studies (51). Consequently, soy is currently
contraindicated for those with an iodine deficiency or thyroid disease (3). For those on
thyroid medication, it is recommended to consume soy at least two hours after taking the
medication (3).
Equol Producers
Recent studies indicate that bone resorption and metabolism may be dependent on the
subject's capacity to produce equol in response to soy (3). Equol is produced by bacterial
fermentation of the soy germ (1) and has a greater estrogen receptor-b affinity than diadzein.
Equol-producing postmenopausal women showed significant lumbar spine bone mineral
density and bone resorption with soy isoflavones (52). People vary in how efficiently they
can make the conversion of daidzein to equol depending on genetics and intestinal bacteria
(13). Findings reported in 2009 suggest 30%-50% of Westerners can produce the bacteriallyderived equol (8,53). Some researchers believe that classifying the equol phenotyping of
individuals may be the key as to whether soy protein diets are effective, but this remains yet
to be established (3). However, animal products, and especially milk products, have also
been identified as dietary sources of equol, so urinary equol concentrations may not represent
actual endogenous production from microbial metabolism in low soy-consuming populations
(54). Research published in Food Bioprocessing Technology still points to isoflavone
activity in the body as being strongly influenced by bioavailability and absorption (55).
Fifty-four postmenopausal Japanese women were classified by equol-producing
status. After soy intervention there was no change in equol concentration in nonproducers
(28). However, in a study reported in 2010 in the Journal of Food Science, researchers
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reported that equol excretion results indicated that younger subjects had higher equolproducer ratios. In addition, 20 non-equol-producing volunteers consumed 1000 mL of
soymilk daily for 16 weeks and 8 of the 20 became equol producers (56). Thus, changing the
diet may change the gut microflora and improve absorption (14). Further, it was reported
that 50% of women and 35.3% of men were equol producers (14,56). In several studies,
Asian men with low equol concentrations demonstrated prostate cancer; however, there
appears to be no association realized in European studies (57). Synthetic equol used in
experiments complicates research, as do cultural differences and lifetime exposure to soy (1).
Early exposure to soy suggests an imprinting effect, which can delay tumor formation and
increase chemoprotective properties (58).
Early Life Intake
Early life soy intake is associated with less aggressive breast cancers (59), and
evidence implies that the period of life when the breast is more susceptible to the effects of
diet is childhood and adolescence (60). Some studies demonstrate that the protective effects
of soy are dependent upon consuming soy from early on and throughout one's lifetime,
although the same protective effect does not hold true for isolated soy protein (21). In a
significant study involving more than 73,000 Shanghai women, a 2009 article in the
American Journal of Clinical Nutrition reported that there was a considerable reduction in
the risk of premenopausal breast cancer in women who consumed high amounts of soy
during adolescence and adulthood (61). Additional studies reveal that Asian breast cancer
survivors who continue consuming soy at customary levels in their diet reveal better
prognoses (21).
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Soy-Based Infant Formula
Reports indicate that between 20% and 36% of the infants in America are fed soybased infant formula (SBIF) (62). Rarely do adults ingest more than 25% of their daily
calories from soy protein, but infants fed SBIF get 100%. According to Michael Shelby,
director of the National Toxicology Program's Center for the Evaluation of Risks to Human
Reproduction (CERHR), "free genistein is thought to have either low or no biological
activity" (63). The data from a pilot study in 2009 concur, reporting "whether the
phytoestrogens in soy formula are biologically active in infants is still an open question"
(62). A study with adults revealed that after a high soy food meal, isoflavones could exceed
postmenopausal estrogen levels by 103 fold (3). However, the half-life of isoflavones is a
short eight hours, and after 24 hours, levels return to baseline values (3,26).
In May 2010, the National Toxicology Program released a draft on soy and its
potential to cause adverse effects. The expert panel concluded there is "minimal concern" for
infants fed SBIF with regard to developmental effects (64). The most cautious interpretation
of the evidence in research thus far can suggest that parents should avoid feeding SBIF,
whenever alternatives are possible, to neonatal male infants through the age of 5 months to
avoid reducing testosterone levels during the period of the testosterone surge (65, 66).
Current studies are underway through the United States Department of Agriculture at
Arkansas Children's Nutrition Center (ACNC) in Little Rock (62). The longitudinal,
prospective controlled feeding study, "The Beginnings Study," began in September of 2002
with 388 full-term healthy infants participating in a controlled feeding study. The study has
four groups of 95 infants each. The first group was exclusively breast-fed; the second group
consumed a cow milk-based formula (CMBF) with DHA; the third group consumed a SBIF

15

with DHA; and the last group was fed a SBIF without DHA. While the ACNC's previous
studies concluded no apparent long-term effects, whether positive or negative, in infants
using SBIF versus CMBF, the current study will continue its investigation into brain
development and functioning, sleep patterns, bone mineralization, metabolism and growth,
body composition, and motor development. These children will be followed through puberty
and will be involved in multiple in-depth check-ups, which began with brief monitoring at 1
month old. Other brief check-ups occurred at 2, 4, and 5 months of age, while extensive
testing (including tissue assessments and imaging) occurred at 3, 6, 9, and 12 months of age
and then annually afterwards (67).
Five years into the study, all children were within normal limits regarding growth and
development (68), and SBIF-fed infants were indistinguishable from non-SBIF-fed infants.
Translational research supports the view that early contact with SBIF and soy foods may
actually offer health advantages such as improved bone composition and protection from
breast cancer (64).
Breast Cancer
It is estimated that nearly 17,000,000 adults and children will be living with cancer in
the United Stated by 2020. In a six-year study of 1,954 patients evaluating the association
between breast cancer survival and soy isoflavone intake, results indicated an inverse
association. Results of the Shanghai Breast Cancer Survival Study reported a significant
decreased risk of death and breast cancer recurrence with soy food consumption (15,17,69).
A study published in Breast Cancer Research Treatment also notes an inverse association,
whether soy isoflavones or soy protein, regardless of tamoxifen treatment or estrogenreceptor expression (70). A study among 358 Korean women, with a mean intake of 76.5 gr
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of soy and 15 mg of isoflavones daily, also reflected no difference between estrogen or
progesterone receptor status (71).
Both tamoxifen and soy isoflavones bind to estrogen receptors, and some studies
suggest soy consumption can improve survival to the degree tamoxifen has exhibited.
Research suggests soy and tamoxifen as adjuvant therapies (72) while other studies find the
same survival rate using soy regardless of whether tamoxifen was used as initial therapy for
breast cancer (73). Whether estrogen or progesterone receptor positive or negative, or in
those taking tamoxifen as endocrine therapy, high isoflavones were associated with lower
recurrence of breast cancer in postmenopausal women (67,74).
More than 150 studies indicate that consuming <100 mg of soy isoflavones daily is
unlikely to elicit adverse effects in breast cancer survivors or healthy individuals (12). The
large Shanghai Women's Health Study provided significant evidence of the protective effect
of soy protein and soy isoflavones against premenopausal breast cancer (59). In Asian
women with a daily intake of approximately 5 gr of soy protein, a one-third reduction in the
risk of pre and postmenopausal breast cancer was recognized (75). For every 10 mg increase
in daily isoflavone intake, a 4% decrease in the risk of breast cancer was observed in Asian
populations (70). However, following migration and Westernization of diet, an increase in
breast cancer incidence among Japanese women is being observed after successive
generations (17).
Prostate Cancer
Men who consumed tofu and soy milk had a 26% reduction in the risk of prostate
cancer (13); however, a one-year study involving 53 men on a daily high isoflavone
supplementation of 450 mg of genistein and 300 mg of daidzein resulted in no change in risk
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factor, equol levels, or PSA levels (76). So although soy may block an enzyme allowing
testosterone's conversion to estrogen, the reduction in prostate cancer risk may be associated
with the type of soy consumed (2,77).
A large, 20-year cohort study of 12,000 Seventh Day Adventist men in the United
States found a 70% reduction in the risk of prostate cancer from consuming soy milk more
than once per day. Four other studies also demonstrate these results. Low concentrations of
genistein were found in Austrian men with prostate cancer, and there exist hypotheses stating
low doses of soy found in Western diets might actually promote cancer (14).
Soy in Cancer Treatments
Genistein modulates cell survival pathways and sensitizes cancer cells to radiation
and chemotherapy. It may protect normal tissue from the damage of cancer treatments, due
to its anti-inflammatory and antioxidant effects. A small study involving children with
cancer concluded that 8 mg of genistein daily, in conjunction with chemotherapy and/or
radiation, resulted in less infection and bone marrow suppression as well as less abdominal
pain and diarrhea. Soy isoflavones prevented side effects from radiation in prostate cancer
patients while enhancing the effectiveness of radiation therapy. At a dosage of 200 mg/d,
bowel, urinary, and adverse sexual symptoms induced by radiation were decreased as
reported in Nutrition and Cancer last year (78).
Guidelines for Future Research
A host of factors may be the cause of varying outcomes in cancer studies, including
an ability to form equol, to absorb soy, and ethnicity. The National Institutes of Health (NIH)
have provided guidance for future clinical research on soy, such as determining lifetime
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exposure, supplement use, and the equol-producing status of subjects. The NIH has
determined that the quality of soy must also be addressed in research studies, as well as using
the type and amount of soy Asians traditionally consume. The NIH also suggests that soy
products should be analyzed for bioactive constituents, growing conditions, harvesting, and
storage conditions, part of plant used, and extraction and processing methods to ensure more
accuracy and consistency in study outcome (79).
Soybean Varieties and Isoflavone Profile
The distribution and retention of isoflavones are significantly affected in the
processing of soybeans (18). The isoflavone content of twenty varieties of soybeans from
China, Russia, Serbia, and the United States was analyzed, with results showing the content
as high as 4.59 gr and as low as 1.45 gr of dried weight (80). When a variety of Brazilian
soybeans were analyzed for isoflavone content, results ranged between 57–188 mg.
Genistein varied from 39-57%, daidzein from 34-47%, and 8-17% for glycitein (81). A
variety of seeds from three Maryland locations examined for isoflavone content indicated a
50% reduction in isoflavones in soybean lines grown for early maturing (82).
There are several industrial techniques used to process soy. When soaking soybeans
to manufacture soymilk, approximately 4-10% of the isoflavones are lost in the water (53).
The isoflavone content of some processed soy has indicated a reduction of as much as 80%,
which affects the estrogen content as well (3). The temperature of the water and the grinding
process can also have a negative impact on isoflavone retention. In processing tofu, the
coagulant can affect the isoflavone yield. To remove compounds deemed undesirable in the
final steps of processing soybeans, an acidified wash produces an additional loss of 22% of
the isoflavone content (53). Interestingly, when patients at high risk for prostate cancer
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consumed alcohol-washed soy protein, it reduced detection of markers for prostate cancer;
however, nonwashed soy protein did not (5).
Soy Manufacturing
The defatting process for soy is typically carried out with hexane. Hexane, a
chemical solvent and byproduct of gasoline refining, was introduced in the 1930s as an
efficient and inexpensive technique to extract proteins from soy. In this processing method,
soybeans are bathed in hexane to separate the protein from the soybean oil (53). In the final
stages of soy processing, hexane is steamed out of the protein, but trace amounts of hexane
are present in the food. Residual concentrations of hexane are reported to be greatest for the
6- to 8-year-old age group, with an estimated daily ingestion of 1.45 mg/kg of body weight.
Extra virgin olive oil has reported residual concentrations as high as 19.1 to 95.3 mg/L (83).
The FDA does not set a limit for hexane residuals in food and does not require testing
for residues by manufacturers. However, hexane residual levels greater than 10 ppm are
prohibited by the European Union. The Cornucopia Institute in the United States found
hexane residuals in soy foods with levels as high at 21 ppm (84) (see Appendix A).
Hexane is highly flammable and presents environmental risks. The Occupational
Safety and Health Administration sets exposure limits to 500 ppm during an eight-hour shift.
Employees working at soy processing facilities experience immediate skin irritation when
exposed to hexane, developing blisters. At 800 ppm for 15 minutes, employees develop
upper respiratory and eye irritation, and narcosis at exposures of 1,000 ppm. The Centers for
Disease Control and Prevention have designated hexane as a neurotoxin. Employees
chronically exposed to hexane develop polyneuropathy, muscle weakness, and eye damage
(84).
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The United States Environmental Protection Agency (EPA) tightly monitors and
controls hexane, considering it a hazardous air pollutant, and heavy fines are imposed with its
excessive release. However, 19 million pounds of hexane were released into the atmosphere
in 2009, with more than two-thirds coming from soy processing plants in the manufacture of
health products, with petrochemical plants and tire factories making up the rest of the
emissions (84). Hexane can create ground-level ozone when reacting with other air
pollutants, also posing health hazards (85). While the EPA considers hexane hazardous, it is
classified as non-carcinogenic based on the lack of data in humans, although when male rats
were exposed to hexane, testicular damage was observed (86), and the incidence of liver and
pituitary tumors increased in female mice. Additionally noted was an increase in the number
of bone marrow cell mutations in rats (87).
Research led by the Cornucopia Institute exposed the soy industry's hexane
manufacturing process in 2009, and since that time many prominent natural foods companies
have changed their extraction method to hydraulic expeller pressing. This process extracts
25-45% less soy protein and isolates than hexane, but companies such as Spectrum Naturals
and Turtle Island Foods believe it is more environmentally responsible (84).
Hexane is not an ingredient or raw product; it is considered a processing aid and is
therefore not listed on the food label. Consumers must be aware that when contacting
companies to inquire about hexane processing, they can receive misleading answers. No
ingredient can be derived from hexane, so careful interpretation should be used if the
company states their soy is not hexane-derived – the real question is whether or not a hexaneextraction process is used. Some companies are not even aware their raw materials were
exposed to hexane when purchasing soy from large suppliers. Careful interpretation must be
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exercised if the company informs consumers that they don't use hexane to process soybeans,
because it doesn't occur in their own food processing plants (84).
Genetically Modified Soybeans
Hexane processing is prohibited in foods labeled organic, as are pesticides and
genetically engineered seeds. Genetically modified (GMO) or genetically engineered (GE)
plants have specific DNA alterations inserted into their genetic material to allow for
herbicide tolerance, to increase insect resistance, or to produce one or more pesticides thus
leading to advantages over crops grown conventionally. In 2007, there were more than 353
million acres in 23 countries growing GMO crops (88). However, genetically modified crops
are problematic in Japan and the European Union (EU) (89). The EU has approved just two
crops (potatoes and maize), so in 2009 when tests indicated trace amounts of unapproved
genetically modified residues in soybeans imported from the United States, all shipments
were halted. Yet the Union's commissioner of agriculture broadcast this statement: "If we
make life too expensive for our farmers by having to source really expensive, completely
GMO free imports, we put up the price and at the end of the day we end up putting our own
farmers out of business and having to import meat from elsewhere. In fact, from countries
that use the very GMO that we're not allowed to use in Europe" (90).
In 1996 Roundup Ready soybeans initiated protests, concerns, and debates on the
safety of genetically modified crops (91), as there were no long-term studies conducted to
indicate the effects genetic modification of plants may have on animals, plants, humans, and
the environment (92). Both animals and humans consume genetically modified crops, the
main of which is soybeans, accounting for 57% of the global biotech area in 2006. Research
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has shown that mice fed genetically modified soybeans since gestation acquired harmful
pancreatic functioning changes at both the microscopic and ultramicroscopic levels (93).
In truth, most studies conducted with GMO plants demonstrate toxic effects on the
liver, pancreas, kidneys, and reproductive organs. Anti-GMO groups argue that genetically
modified foods should be thoroughly tested in long-term clinical studies to determine the
effect on human health, also noting that GMO foods increase anti-nutrients, pose problems
for allergic responses, and could transfer antibiotic-resistant genes to bacteria in the
gastrointestinal tract. Studies reveal these viral DNA fragments have been detected in the
milk from cows and in the tissues of mice and chicken fed GMO crops (94).
In a study conducted in 2008, Roundup Ready soybeans caused inflammation in the
intestinal cells of salmon, leading researchers to question whether long-term use of
genetically modified crops may lead to chronic inflammation of the gastrointestinal tract and
ultimately lead to cancer. Exposing infants and children to GMO foods also raises concern.
When pregnant mice were fed genetically modified foods, DNA fragments were detectible in
both fetuses and newborns, indicating a transfer through the placenta. A study in Russia
resulted in 56% of rats dying when fed GMO soy, and also suggested that maternal ingestion
could be a mutagenic factor for developing fetuses (94). Other recent studies indicate that
Roundup Ready soybeans interfere with estrogen production, depress respiratory activity,
alter the inner membrane of the mitochondria, and point to an increase in the physiological
aging process (95).
Additionally, there is concern about the ability of genetically modified foods to either
change the level of expression in genes by turning on those previously not being expressed,
or perhaps even silencing certain genes. This emphasizes the fact that the duration of
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exposure in studies must be increased and genetically modified foods more thoroughly
studied in order to determine toxicity and reach sound conclusions as to the safety of GMO
foods (94). While there appear to be no adverse effects in short-term studies,
multigenerational studies have not yet been conducted, although one long-term study
indicated a reduction of 10% in the animal's life span (88).
When limiting studies to a single generation, reproductive capacity is not assessable.
Concerns surround normal ovulation, fertilization, and implantation for females, and
testicular health and accessory organ functioning in males. Multigenerational issues for both
sexes include developmental effects in utero, postnatally, puberty, and lifetime reproductive
health, all of which have not been studied (88).
Regulatory tests are not mandatory nor conducted independently, and results are kept
secret by manufacturers of genetically modified crops. In fact, some manufacturers' studies
concluded that no further testing was necessary even after noting the possibility of
hepatorenal toxicities. In 2010, the International Journal of Biological Sciences published an
article revealing that the authors had obtained the previously hidden raw data from
Monsanto, through lawyers and a court order. In reviewing three toxicological tests that
Monsanto conducted, several shortcomings of the studies' designs were noted, specifically:
too small a number of animals were included in the study; only 10% of the animals were
analyzed biochemically; and each test was performed only once on rats fed for a mere 3
months' time, all suggesting controversial protocols with Monsanto and the international
committees who did not reject the results of such experiments (96).
Moreover, the papers obtained by court order indicate Monsanto's studies revealed an
increase in the heart size in male rats of 11% as well as signs of "chronic progressive
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nephropathy," while females demonstrated an increase in plasmatic triglycerides. Monsanto
had previously sought to prevent routine independent and reproducible studies by attempting
to block confidential access to the raw data, until losing their case in the Court of Appeals in
Germany. The authors noted that studies funded by industry do not suggest the possible side
effects of genetically modified foods, and liken industry-funded soy studies to the
controversy surrounding bisphenol A where no adverse effects were cited in industry-funded
studies and yet hazards were highlighted in 90% of government-funded studies (96).
Consumers' Image of Soy
Soy food consumption is highest among Asian Americans, Seventh Day Adventists,
and vegetarians. Those who do not consume soy perceive soy food as something for people
with allergies and for Asians, vegetarians, and hippies (97). According to the United
Soybean Board, 8 in 10 consumers in 2010 consistently rated soy foods as healthy for the
heart, understood soy to reduce the risk of certain cancers, and believed that it was helpful for
weight management. The United Soybean Board also reports that consumers gather
information on health from television news (47%), the Internet (44%), magazines (37%),
word of mouth (35%), and the newspaper (31%). Only 17% of consumers obtain
information from a health professional (98).
Credibility of Soy Information
For the past several years, some lay media have been successful in delivering a
message on the dangers of soy consumption. One of the more prominent groups is the
Weston A. Price Foundation (WAPF). Weston Price passed away in 1948 and although his
training was in dentistry, he was fascinated with nutrition. This group, headed by Sally
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Fallon (a self-proclaimed health activist with no nutritional training), Mary Enig, PhD (a
licensed nutritionist), and James Mercola, D.O., claim SBIF inhibits the absorption of
nutrients needed by infants and “contains the equivalent of at least five birth control pills per
day” (99). Along with strong anti-soy and anti-vegetarian sentiments, the group promotes
"Nourishing Traditions," which strongly advocates a diet high in butter, cream, milk, meat,
and eggs and vehemently opposes low-fat diets, high-fructose corn syrup, and the idea that
elevated blood serum cholesterol is dangerous (100).
In the past (up to the year 2006), the Foundation suggested that when children are fed
soy they experience “extreme emotional behavior, learning disabilities, depressed thyroid,
pituitary insufficiency, irritable bowel syndrome, asthma and immune problems.” Most
disturbing is their message that feeding male infants SBIF can alter their future sexual
orientation and their related suggestion that mothers who can't breastfeed prepare homemade
formula based on whole milk, or give infants a homemade formula made from liver (100).
Most of these statements have been removed from the Foundation's website, but other noncredible information remains.
In reviewing "Soy Alert!" on the WAPF website, 67 articles were featured by various
authors on the dangers of soy. Oddly, most of these authors have no formal training, and
they referenced articles that bear no meaning in supporting what they are reporting in their
writing. For instance, Linda Joyce Forristal has CCP and MTA as her credentials; however,
these credentials stand for Certified Culinary Professional and Master's in Tourism
Administration. Another author, Maria Van Heemstra, trains people in the construction
industry and promotes solar cooking, while Andreas Schuld belongs to Parents of Fluoride
Poisoned Children. Not to imply that these individuals cannot do research to back up their
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articles, but out of the 67 articles only approximately 20% included references, and none of
those references were to recently published studies or research conducted in the past ten
years (100).
In order to access Dr. James Mercola's website, one must subscribe. Articles and
videos indicate the number of times they have been viewed; for instance, the anti-soy video
"This 'Miracle Health Food' Has Been Linked to Brain Damage and Breast Cancer" has been
viewed 496,209 times, while the article "The Evidence Against Soy" has been viewed
197,932 times as of November 2011. Dr. Mercola maintains the only safe way to consume
soy is in its fermented form, such as in natto, tempeh, miso, and soy sauce. Interestingly, out
of 72 "endnotes," his work referenced studies mostly conducted in the 1970s and dated as far
back as 1925. There are very few references cited for studies conducted on soy over the past
decade (101).
A third soy adversary is New York Times bestselling author Ann Louise Gittleman.
Ms. Gittleman refers to herself as a "Dr. Ann Louise, First Lady of Nutrition" after obtaining
a degree in nutrition upon completing a non-accredited, distance-learning course in 2002
from the now-defunct Clayton College once based in Birmingham, Alabama. On Ms.
Gittleman's website one article suggests, "Manufactured soy is linked to decreased fertility
and possible thyroid problems." She cites nine sources to support her claim. Two of the
sources reference her own books, and two of the remaining seven are duplicate articles.
Upon reviewing the remaining five sources, an interesting discrepancy was discovered (102).
Ms. Gittleman's first article from PubMed merely suggests soy does not improve lipid
profiles in postmenopausal women and has nothing to do with fertility or thyroid issues. The
second article simply lists soy as one of the ten most frequent foods with the potential of
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triggering allergic responses, again never mentioning thyroid or fertility issues. A third
article compares dairy with soy and reports that "soy exerted no significant effect." In like
fashion, the three remaining referenced works bear no relevance to support her article. It's
painfully apparent there is an incredibly strong need to educate the public on how to obtain
accurate health information on soy (102).
Health Professionals and Soy Recommendations
With more than 2,000 peer-reviewed articles relating to soy published each year,
health professionals have volumes of credible information for continuous updates on soy.
The United Soybean Board reports that 80% of dietitians view soy favorably (98), but what
about the other 20%? The controversy over soy and breast cancer leaves some health
practitioners uneasy. On the one hand, clinicians are advised to suggest that soy food
consumption by breast cancer patients is probably safe and may even offer long-term
protection from recurrence (15). Other studies suggest soy can stimulate cancer cells and
should be avoided (2). The American Cancer Society recommends breast cancer survivors
avoid high intakes of soy (13). Nurses are advised to include soy in dietary assessments and
to become more knowledgeable regarding soy and its components (103).
When advising patients, clinicians should be aware of both the quality and quantity of
soy consumed (15) although this can be problematic when the content of isolates is not
labeled on soy foods. Iowa State University has created the first isoflavone database of foods
analyzed for their content of genistein, diadzein, and glycitein. The database includes a
Confidence Code to indicate the quality of the data. The entire document is attached to this
thesis as Appendix B, Documentation for the USDA-Iowa State University Isoflavones
Database.
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This thesis examines consumer awareness of soy along with where consumers
obtained the information enabling them to form their opinion on the health implications of
soy. Therefore, the following research questions are proposed:
RQ1: What is the current understanding of the public regarding health implications
and the ingestion of soy for certain health conditions?
RQ2: Where have consumers obtained information regarding the health implications
of soy that contributed to their opinions and beliefs?
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Chapter 3: Research Methodology
Materials and Methods
A convenience sample of consumers was selected to provide information in regard to
their perceptions regarding soy's health implications. Participants were asked to complete a
survey with five questions assessing their awareness of the health implications of soy. The
questions were developed following a review of current literature. The first question listed
12 health issues and asked respondents to rate whether they believed soy was "beneficial,"
"detrimental," or had "no effect," for each of the conditions listed. If a respondent did not
have an opinion or was uncertain, his or her response was indicated as "not sure."
The second question asked subjects where they obtained their information on soy's
health implications. The third question inquired as to whether participants felt there were
certain conditions where soy would be contraindicated. The fourth question inquired as to
whether the respondent consumed soy and, if so, in what form. The fifth question assessed
the subject's knowledge of the manufacturing process for non-organic soy product.
Two additional questions sought information on the participant's demographics, and
any qualitative comments participants felt the desire to share regarding soy, in order to more
fully explore specific consumer opinions. A copy of the survey is available as Appendix C.
By the third group of consumers, no new information was obtained, indicating that an
adequate sample had been realized and that the study had reached its point of saturation.

Study Population
Participants were individuals interested in learning more about holistic health and
complementary medicine. A small number (25%) of health professionals were in attendance
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at the seminars; however, for the vast majority this was the first class they had ever attended
on health. Prior to starting each seminar, Power Point slides were shown to describe this
study, and participants were asked to voluntarily complete a survey questionnaire regarding
soy, as approved by Eastern Michigan University's Human Subjects Review Committee
(Appendix D).
Between August 26 and November 4, 2011, a convenience sample of 242 individuals
in six states consented to participate and complete the questionnaire:
Atlanta, GA – August 27
San Diego, CA - September 9
Birmingham, AL - September 17
Altoona, PA - October 8
Ann Arbor, MI - October 22
Buffalo, NY – November 5
There were significantly fewer males (15%) than females (85%). The majority of the
population was Caucasian (82%), followed by African Americans (12%) and other race
(6%). The mean age was 52.42 (range: 18-92 y). Initially, there was some concern that
individuals participating in the study would be more health conscious than average and
would skew the data. However, only 25% of participants were employed in the health field.
Of the remaining, 31% of study participants were professionals or worked in an office, 17%
were retired, 12% were employed in sales, 11% were homemakers, 7% were in academia,
7% held jobs as laborers, 5% were business owners, and 9% had various other professions.
Surveys automatically protected each participant's confidentiality as no name was
entered, nor other data considered private regarding the participant's location, health status,
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financial information, or educational background. Upon completion of the questionnaire,
participants in the survey were compensated with a sample of the herbal remedy, "Solstic
Immune."
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Chapter 4: Results and Discussion
Analysis and Discussion of Findings
The aim of the present study was to determine consumers' opinions and perceptions
of soy in reference to its perceived health implications. Further, the study sought to compare
attitudes regarding soy by identifying where consumers acquired the information from which
they formed their beliefs. A structured questionnaire was administered to a convenience
sample in order to collect information from participants regarding their awareness of the
health implications of soy. Demographic and lifestyle characteristics solicited included race,
age, occupation, whether they were cancer survivors, and whether they consumed soy and, if
so, in which form. Additional information was collected as to where they obtained their
impressions of soy's safety. Last, participants were invited to share any qualitative comments
regarding the consumption of soy.
Findings regarding views of soy as beneficial and detrimental are presented, as well
as the uncertainty expressed from the majority of respondents. This chapter will also discuss
findings by subgroups, namely differences in opinions between men and women; those who
are in the health profession and those who aren't; those who are cancer survivors and those
who have not had cancer; advocates and non-advocates of the Weston Price/James Mercola
message; consumers and non-consumers of soy; and those who have researched soy further
and those who have not done so. The results clearly demonstrate a strong need for consumers
across the nation to have access to accurate and up-to-date health education in regard to soy.

RQ1: What is the current understanding of the public regarding health implications
and the ingestion of soy for certain health conditions?
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A tremend
dous amoun
nt of uncertaiinty exists inn the public'ss understandding of soy.
Figurre 1 below illlustrates thee total respon
nses recordedd from the ssurvey.
Figurre 1. Total Responses
R
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The largest percentag
ge of responsses for benefficial health claims was oobserved in
regarrd to menopaause rather th
han soy's ben
neficial effe ct on cardiovvascular disease as baseed on
the FDA's approv
ved health cllaims pertain
ning to soy: "25 grams oof soy proteiin a day, as ppart
d low in saaturated fat and
a cholesteerol, may redduce the riskk of heart dissease. A servving
of a diet
of [naame of food]] supplies __
_ grams of so
oy protein," or "Diets loow in saturated fat and
choleesterol that in
nclude 25 grrams of soy protein
p
a dayy may reducce the risk off heart diseasse.
One serving
s
of [n
name of food
d] provides __
_ grams of soy protein"" (104). Otheer results
indicated that tho
ose most ofteen designatin
ng soy as benneficial weree survey parrticipants in
%), and the soy consumeer (29%).
Califfornia (40%), those in thee health proffession (32%
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Figurre 2. Averag
ge Consumerr Perception
n of Soy as B
Beneficial
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These datta in Figure 2 clearly ind
dicate the pubblic's knowlledge that sooy possesses
estrog
genic properrties, as evid
denced by thee most favorrable responnse for use inn menopausee.
Qualiitative statem
ments from survey
s
particcipants echo this understtanding:
• "Soy soaaks up toxin
ns from the so
oil and has xxenoestrogenns."
• "I was already
a
estrog
gen dominan
nt and it exaacerbated a loot of my connditions."
• "Soy is not
n good forr men. Makees them havee breasts."
• "One caan get too mu
uch and increease estrogeen."
• "Fat cellls and hair fo
ollicles make estrogen soo few womeen need soy.""
• "My gen
neral practitiioner approv
ved my consuumption of ssoy for estroogen."
• "Heard that
t it's good
d for menopaause but alsoo that you caan get too muuch and it haas
side effe
fects."
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While oveerall responsses indicated
d soy as leastt detrimentaal in regard too cardiovasccular
health
h as shown in
i Figure 3, participants
p
felt stronglyy that soy waas most detriimental to booth
breasst and thyroid
d health, witth infancy, childhood,
c
annd adolescennce followinng closely beehind.
Figurre 3. Average Consumerr Perception of Soy as Detrimental
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ost often speccifying soy as
a detrimenttal were a suubgroup of participants
Those mo
identifying themsselves as adv
vocates of Dr.
D James Meercola's anti--soy messagee or memberrs of
W
A Priice Foundatiion, defined by the authoor as "Price/M
Mercola." It is interestinng to
the Weston
note that
t while th
he average reesponse overrall indicatess only 5% off survey partticipants
attrib
buted soy as detrimental to cardiovasscular healthh the Price/M
Mercola grouup averaged 224%.
nomenon waas intriguing,, and upon fuurther investtigation it beecame apparrent
This phen
that this small gro
oup's respon
nses became the outliers in nearly evvery categoryy observed. Out
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of 24
42 participan
nts, a mere 7%
% belonged to the subgrroup definedd as "Price/M
Mercola," butt
their responses diiffered significantly from
m the "Non M
Mercola" grooup.
Figurre 4. Differeences in Opin
nions Betweeen Non Pricce/Mercola aand Price/Meercola Membbers
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While 26%
% of the aveerage overalll responses iindicated soyy as most deetrimental onn
breasst health, 38%
% of cancer survivors also believed soy to be deetrimental to breast healtth.
Price/Mercola meembers veheemently, at tiimes, opposeed soy, withh 41% regardding it as
detrim
mental for brreast health, 65% classiffying it as deetrimental foor infancy annd 59%
categ
gorizing soy as detrimenttal for childrren/adolesceents and thyrroid functionning.
Previous research
r
ind
dicates that a consumer's awareness oof soy's health benefits is
positiively associaated with add
ding soy into
o their diet ((106). Particcipants weree asked to deefine
wheth
her they werre soy consu
umers. Contrrary to the 2 008 United Soybean Naational Reporrt
that 62%
6
of consu
umers eat orr drink soy (9
98), the prevvalence of thhis study's paarticipants
consu
uming soy was
w 54% of whom
w
24% drank
d
soymillk, 44% ate tofu, 39% coonsumed a ssoy
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protein powder, and
a 28% obttained soy in
n other foodss such as veggetarian meaat substitutess and
protein bars.
m the 27 surv
vey participaants in Califoornia (approxximately 11%) became aan
Data from
outlieer of anotherr type. When
n comparing
g overall aveerages for sooy and its efffect on healthh
issues, Californiaans most ofteen reported the
t largest coonsumption of soy and ggave higher
respo
onses indicatting soy as beneficial, ass shown in Fiigure 5.
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In fact 68% of respon
ndents in Callifornia claim
med to consuume soy products, with 332%
drink
king soymilk
k, 36% eating
g tofu, and 48%
4
consum
ming soy prottein powder. Consumptiion
patterrns from all six states, ass well as sub
bgroups from
m the total poopulation, arre illustratedd in
Figurre 6. Califorrnians' consu
umption patttern of "otheer" (classifiedd as vegetariian meat
produ
ucts, protein bars, soy saauce, and soy
ybeans) was the only cattegory of soyy food intakee
surpaassed by another subgrou
up or populaation.
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Figure 6. Co
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Interestingly, consum
mption of soy
y products diid occur in bboth the Pricee/Mercola grroup
and th
he cancer su
urvivor group
p, although all
a subgroupps felt soy shhould be conttraindicated
underr certain heaalth condition
ns, as presen
nted in Figurre 7.
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Once agaiin, Price/Meercola memb
bers perceiveed the highesst contraindiication, whille
thosee who have not
n studied so
oy deemed it
i to be least contraindicaated. Most oof the qualitaative
statem
ments from participants
p
suggested th
he largest concern stemm
med from theeir belief in
estrog
gen's ability to induce caancer:
• "My frieend who is vegan
v
had caancer and feeels that it cam
me from her huge intakee of
soy."
• "I have a friend who
o consumed high amountts and develloped stage 4 cancer."
• "Stay aw
way from soy
y because off breast canccer."
• "Heard some
s
concerrns with soy and breast ccancer, inforrmation onlinne is VERY
contrad
dictory."
• "Don't eat
e soy now since
s
breast cancer."
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Survey paarticipants ex
xpressed mu
uch uncertainnty as to the effects soy hhad on certaain
health
h conditionss. Although
h the majority
y of responddents were noot aware of tthe hexane
proceessing of soy
y (except forr the Price/M
Mercola subggroup), manyy were awaree of the issuees
surrounding geneetically modiified soy. Fiigure 8 indiccates the pauucity of know
wledge of
consu
umers regard
ding the chem
mical extracction of soy pprotein and iits possible ccarcinogenicc
effectt on the body
y.
Figurre 8. Consum
mer Knowleedge of Hexaane Processinng
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The term GMO soy caan be negativ
vely perceivved by consuumers and thhe author notted
on seeveral occasiions pro-soy groups did not
n use the tterm any lonnger. In the 18th Annual
Surveey Report off 2011, the United
U
Soybeean Board avvoids use off the GMO teerm, instead
assocciating biotecchnology wiith the enviro
onment and presenting iit in a way thhat sounds
conviincingly com
mplimentary. The Annuaal Survey repports, "Bioteech soybeanss will
increasingly offerr direct conssumer benefiits in the com
ming years" and will hellp to grow "m
more
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food with less land and water to feed a hungry world in an environmentally sustainable way"
(106).
However, while none of the additional qualitative statements that participants offered
on surveys mentioned the environmentally hazardous soy hexane manufacturing process, out
of the additional statements received, 21% cited the dangers of GMO soy as most
problematic:
• "I think GMO soy is causing most of the detrimental health conditions."
• "I'm still unclear about soy. Hear most soybeans are GMO so limit my intake."
• "Opposed to soy due to GMOs."
• "20 years ago soy was good. Stay away from GMO."
• "No GMO for sure."
• "Monsanto and GMO are problematic in my mind."
• "Very concerned about GMO. I feel this is causing the soy problems."
There remains a tremendous amount of doubt concerning the health implications of
soy as shown in Figure 9, and oddly the uncertainty regarding soy's health effect on
cardiovascular health remains the highest. Weston A. Price Foundation members petitioned
the FDA to retract the "soy-prevents-heart disease claim." In 2009 Foundation officers
delivered a 65-page petition to FDA offices and asked for a public hearing on issues raised in
the petition (107). The Foundation's website can be quite convincing to those not
understanding how to determine the credibility of health information.
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Figure 9. Total "Uncertain" Responses to Soy's Effect on Health
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Qualitative statements gathered from survey data reflect participants' uncertainty with
soy:
• "Very confused about all the info on soy."
• "I have mixed feelings."
• "It seems there is a lot of conflicting information regarding soy."
• "There is a lot of confusion over soy. I hear good and bad."
• "So much information going both ways, I don't know what to believe."

RQ2: Where have consumers obtained information regarding the health implications
of soy that contributed to their opinions and beliefs?
A 2004 study found the Internet to be the most frequent source for seeking health
information, followed by television, magazines, and family and friends (108). While the
United Soybean Board reported the same sequence of health information-seeking behaviors
in 2011 (106), results of this study indicate magazines represent the main source of
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inform
mation used
d by participaants when seeeking perso nal health innformation, eexcept, of
coursse, for the Prrice/Mercolaa subgroup.
Figure 10
0 examines where
w
survey
y participantss obtain theiir health infoormation andd
includes subgroups for maless and females and Price/M
Mercola mem
mbers. Of particular inteerest
is thaat 100% of Price/Mercol
P
a followers first
f
and foreemost receivve their healtth informatioon
via th
he Internet, specifically
s
on
o the websiites of the W
Weston A. Priice Foundatiion and Dr.
James Mercola. Also
A interesting to note is the extrem
mely low num
mber of malles seeking hhealth
inform
mation from
m a physician
n and their hiigh responsee in seeking hhealth inform
mation from
ma
familly member or
o friend, which is consisstent with othher studies. In the presennt study,
howeever, femaless rated magaazines and neewspapers a s the most common sourrce for obtaiining
health
h informatio
on. It is appaarent that wo
omen are moore proactivee in seeking health-relateed
inform
mation than men, as has also been id
dentified in oother researcch (109).
Figurre 10. Wheree Health Info
ormation Is Obtained
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Unfortunately, not all health information is credible. Websites can be authored and
published by anyone without expert/peer review or editorial processes, and thus consumers
are relying on the site's credibility based on brand, visual design, and site traffic. With 80%
of the adult population seeking health-related information on the Internet annually, the
possibility of acquiring misinformation is paramount (109).
This study may have discovered a possible discrepancy in previous soy reporting by
identifying a group of extreme anti-soy members and their associated pattern of
nonconsumption of soy due to their awareness of GMO soy and detrimental soy
manufacturing practices and their strong adherence to the (albeit biased) messages of the
Weston A. Price Foundation and Dr. James Mercola.
The author questions whether the perceived danger of soy is more likely due to the
soybean's unfortunate close affiliation with both GMO and hexane. This affiliation gives the
illusion that the bean itself is dangerous for consumption when, in fact, the DNA fragments
from GMO soy and the carcinogenic factors associated with hexane may be the reason for
soy's sometimes detrimental effect on the body – an effect that would not be the case in an
organic, non-GMO, unprocessed soybean.
The author suggests that perhaps the National Institutes of Health guidelines for
future clinical research on soy (79) should include the variables hexane processed and GMO
soybeans in order to obtain clearer scientific evidence to help support or dispel health claims
made to consumers and lessen their uncertainty about soy. If the results conclude that all
variables have been accounted for and soy is positively associated with health gain,
consumers will feel less angst about increasing regular soy consumption.
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The insight gained from the findings in this study provide valuable information
regarding consumers' opinions on the health implications of soy, where they obtain their
health information, and their resulting soy consumption patterns, as well as identifying antisoy groups.
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Chapter 5: Conclusion and Recommendations
Summary of Findings
To the author's knowledge, this is the first study to evaluate the relationship between
an awareness of soy's health implications and where the study population obtained
information that helped form their perceptions. The major findings in this study were the
sizeable amount of uncertainty consumers have regarding soy as well as the identification of
strong consumer attitudes and beliefs emanating from anti-soy members.
Misinformation and uncertainty leave consumers asking for clarification. Of the
individuals sharing any closing thoughts on soy, 27% claimed they had little knowledge
regarding soy, admitted that they were confused by all the conflicting information, or
expressed a desire to learn more.
• "My knowledge is very limited. Want to hear more about soy."
• "Don't know much at all, other than hearing it was a better alternative to processed
milk."
• "Totally ignorant of the facts. How often should you consume soy per week?"
• "Really don't know a lot about soy. Tasted soy milk but really didn't like it."
• "I would like to know more about it."
• "Not completely sure of all the facts to make a final decision, need to read more
research."
Conclusion and Practical Implications
Soy has been a key plant source of protein for Asians for thousands of years, and
many studies suggest soy to be a protective factor for humans by reducing the risk of a
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variety of cancers including colorectal, gynecological, and breast (6). It has also been
suggested that when children and adolescents are exposed to isoflavones, with as little as one
serving of soy daily, the risk factors for cancer are reduced by as much as 50% (60), and
existing data suggest that normal dietary levels of isoflavones do not adversely impact either
the progression or the risk of estrogen-dependent cancers (3).
However, some Westerners exceed 100 mg/d of soy isoflavones, an amount that <5%
of Asians consume. In addition Asians typically eat soy that is minimally processed, while
Westerners consume processed soy foods in the form of vegetarian meat alternatives, soy
protein powders, and capsules, which results in isoflavone amounts above and beyond those
consumed in Asian countries. Studies have found when mice were exposed to processed soy
foods, tumor growth increased in comparison to mice consuming soy that was less processed,
raising the question of whether those with cancer should be concerned with processed soy
(110).
The United States Department of Agriculture (USDA) is now recommending soy
foods. Just last year the USDA released their dietary guidelines to include soy as an
alternative source to lean protein (111). In response to one of the WAPF claims that Asians
eat very little soy, Taiwanese author Jean Tsai writes, "Have any of these people lived in an
Asian home? Do they know any Asians? I happen to know a lot of Asians that I'm related to
and soy products are pounded on a regular basis. No one I know has a tiny 7 grams a sitting.
This is bogus." Her humor continues when addressing the anti-soy contingents who suggest
phytoestrogens feminize boys and lower their sperm count; "Last time I checked, Asia was
being accused of overpopulation. There doesn't seem to be any low sperm count there. And
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if soy was super-feminizing, you would think the average Asian woman would have the
figure of Pamela Anderson" (112).
Dr. Andrew Weil concurs with Ms. Tsai's pro-soy stand and is also aware of the
"internet paranoia on the subject of soy." Dr. Weil adds that Japanese women consume a lot
of soy and yet have 1/5 the rate of breast cancer of Western women. He suggests that soy
can interfere with thyroid functioning but "only if you have a thyroid disorder to begin with"
or do not have enough iodine in the diet (113). Consumers need to have accurate information
on soy, as do health educators and other health professionals.
In summary of the research outcomes as they stand today, it is suggested that people
limit soy if they have either an iodine deficiency or a diagnosed thyroid disorder, if they are
allergic to it, or just don't care for it. Further recommendations are to go light on processed
soy but enjoy it in its fermented form, and buy organic and non-genetically modified soy
when available. It is advised to use caution when taking soy isoflavone supplements until
further research has been completed and, last, avoid Dr. James Mercola and the Weston A.
Price Foundation's soy fear-mongering.
Limitations
This study was an attempt to describe consumer beliefs and awareness of soy.
Despite the strength of this study, limitations exist. Due to recruitment in a health education
setting, a knowledge bias may exist, as attendees may have an interest in complementary
therapies and have a greater knowledge of soy than the broader population. Initially, there
was some concern that individuals participating in the study would be more health conscious
than average and would skew the data. However, only 25% of participants were employed in
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the health field. Last, given the small sample size and the fundamental limits of surveys,
caution should be exercised when generalizing and interpreting the results.
However, in spite of the limitations, the findings suggest practical applications and
provide new research questions such as whether the soy used in experimental designs is
GMO/non-GMO or hexane processed. In addition, when surveying consumers on their
beliefs regarding soy, defining where consumers get their health information may make for
more sound data analysis. Finally, with the amount of uncertainty represented in the survey
results on the part of consumers, it is of great necessity that health professionals and health
educators are educated on soy and are cognizant as to the credibility of the information they
share with consumers.
Recommendations for Future Research
With the lack of consistency in studies examining soy, future studies are needed to
determine what is safe to consume and in which amounts. Ideally, future studies should
evaluate the added variables of GMO/non-GMO and hexane-processed soy to extend current
findings when including information on the source, processing, environmental conditions,
seed source, and nutritional composition of the soybeans used. It may also be beneficial to
determine iodine status in test subjects. These studies are warranted to confirm the
association of soy consumption with health implications. Future surveys and research
regarding soy consumption should also be extended to include nutrition educators and health
professionals in order to determine the accuracy of their knowledge on the subject, due to
their interactions with consumers.
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Summary
With soy consumption increasing worldwide, research has exploded, suggesting soy's
ability to reduce the risk of disease. Soy is not a hormone or a carcinogen. It has just been
misrepresented. It isn't a miracle food nor is it a dangerous food. When properly grown,
manufactured, prepared, and consumed in acceptable amounts, soy can be a useful protein
source to include in a healthy diet with 25 gr/d of whole soy food protein considered
beneficial to health, and the avoidance of isolated soybean components.
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Appendix A Cornucopia Guide to Hexane-Extracted Soy Foods

Guide to hexane-extracted soy in nutrition bars.
http://cornucopia.org/hexane-guides/hexane_guide_bars.htmlhttp://cornucopia.org/hexaneguides/hexane_guide_bars.html25

Brand
Name

Product

Ownership

Alpsnack

All bars

Amazing
Grass

Green Superfood
Independent Company
Bars
Independent Company
(Mountain Organic
Foods)

Bumble Bar All bars

Independent Company

"C" Bars

Clif Nectar Nectar Bars

Free of HexaneExtracted Soy
Protein?

Independent Company

Bear Fruit All bars

Clif "C"
Bar

Organic
Status

Independent Company 70% Organic
(Clif Bar)
Ingredients

Independent Company
(Clif Bar)
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Caution: Other Clif
products, including
Clif Bars, contain
non-organic soy
protein ingredients,
likely hexaneextracted
Caution: Other Clif
products, including
Clif Bars, contain
non-organic soy
protein ingredients,
likely hexaneextracted

Garden of
Living Foods bars Independent Company
Life

Genisoy

Organic Bars

Independent Company

Hammer

All bars

Independent Company

Honey
Stinger

Protein Bars

Caution: Other
Genisoy products
contain non-organic
soy protein
ingredients, likely
hexane-extracted

Independent Company Not organic

Kind Plus Antioxidants bars Independent Company Not organic

Larabar

All bars

Public Corporation
(General Mills)

NuGo

Organic Bars

Independent Company

Nutiva

All bars

Independent Company

Odwalla

Original Bars,
Superfood Bars,
Chewy Nut Bars

Public
Corporation(CocaCola)

Nature's
Path

Optimum Bars

Independent Company

Caution: Other Honey
Stinger products
contain non-organic
soy protein
ingredients, likely
hexane-extracted
Caution: Other Kind
Plus products contain
nonorganic soy
protein ingredients,
likely hexaneextracted

Not organic
Caution: Other NuGo
products contain
nonorganic soy
protein ingredients,
likely hexaneextracted

Not organic
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Caution: Odwalla's
Protein Bar contains
nonorganic soy
protein isolate, likely
hexane-extracted.
Most Odwalla contain
hexane-extracted soy
lecithin, a minor
ingredient

Organic
Food Bar

All bars

Independent Company

Potent
Foods

Maca Bars and
Potent Life bars

Independent Company

Pure

Pure Bars

Independent Company

Raw
All Bars
Revolution

Independent Company

SoyJoy

All bars

Independent Company
Not organic
(Pharmavite)

Vega

Vega Whole Food Independent Company
Not organic
Bars
(Sequel Naturals)

Wild Bar

All bars

Independent Company

Zen
Organic
Foods

All bars

Independent Company

Balance
Bar

Original, Bare,
Private Equity Firm
Gold and Carbwell
Not organic
(Brynwood Partners)
Bars

Can Do Kid All bars

Independent Company Not organic

Clif Bar

Independent Company 70% Organic
(Clif Bar)
Ingredients

All Clif bars

70

Clif
Builder's
Bar

All Builder's bars

Clif Mojo
All Mojo bars
Bar

Genisoy

Independent Company
Not organic
(Clif Bar)

Independent Company 70% Organic
(Clif Bar)
Ingredients

Non-Organic Bars,
including Ultra
Independent Company Not organic
and Protein
Crunch bars

Greens Plus Energy bars

Independent Company
(Orange Peel
Not organic
International)

Honey
Stinger

Energy bars

Independent Company Not organic

Kind Plus Protein bars

Independent Company
(Peaceworks
Not organic
Holdings)

Luna Bar

Independent Company 70% Organic
(Clif Bar)
Ingredients

All Bars

Luna
All Bars
Protein Bar

NuGo

Independent Company
Not organic
(Clif Bar)

Non-organic bars Independent Company Not organic
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Odwalla

Protein Bars

Public Corporation
(Coca-Cola)

Not organic

Power Bar

Harvest and Nut
Naturals Bars

Public Corporation
(Nestle)

Not organic

Pria Bar

All bars

Public Corporation
(Nestle)

Not organic

Promax

Promax and
Promax 70 Bars

Private Equity Firm
(Marwit Capital)

Not organic

Pure
Protein

All bars

Independent Company Not organic

Think

Think Thin Protein
Independent Company Not organic
and Crunch bars

Whole
Public Corporation
Super Greens Bar
Not organic
Foods 365
(Whole Foods Market)

Zone
Perfect

Zone Perfect and Public Corporation
Fruitified Bars
(Abbott Nutrition)

Not organic

72

Guide to hexane-extracted soy in meat alternatives.
http://cornucopia.org/hexane-guides/hexane_guide_meat_alternatives.htmlhttp://cornucopia.org/hexaneguides/hexane_guide_meat_alternatives.html56

Brand Name

Product

Ownership

Organic
Status

Amy's
Kitchen

All Products

70%
Independent
Organic
Company
Ingredients

Asherah's
Gourmet

All Products

Independent
Company

Boca

"Made With Organic Soy"
patties, burgers and links

Public
Corporation 70%
(Kraft Organic
Philip
Ingredients
Morris)

Field Roast
Grain Meat

All Products

Independent Not
Company
Organic

"Garden
Public
Not
GardenburgerVegan,""Gourmet,""Original"Corporation
Organic
and "Sun Dried Tomato Basil" (Kellogg's)

Helen's
Kitchen

All Products

Morningstar "Made With Organic Soy"
Farms
burgers and patties

Free of
HexaneExtracted Soy
Protein?

Caution: Other
Boca products
contain
nonorganic soy
protein
ingredients,
likely hexaneextracted

Caution: Other
Gardenburger
products contain
non-organic soy
protein, likely
hexaneextracted

Independent
Company

Public
70%
Corporation Organic
(Kellogg's) Ingredients
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Caution: Other
Morningstar
products contain
non-organic soy
protein

ingredients,
likely hexaneextracted
Primm Spring
All Products
Foods

Independent Not
Company
Organic

Soy Deli

Tofu Burger

Independent
Not
Company
Organic
(Quonghop)

Tofu Shop

All Veggie Burgers

Independent
Company

All Products

Independent
Company
Not
(Turtle IslandOrganic
Foods)

Tofurky

Trader Joe's Veg Masala Burger

Independent Not
Company
Organic

Trader Joe's Organic Tofu Burger

Independent
Company

Wildwood

All Products

Independent
Company

Boca

Public
Corporation
Not
Chick'n, Burgers and Sausages (Kraft Organic
Philip
Morris)

Dr. Praeger's

Veggie Burgers, Veggieballs
and Veggiepockets

Independent Not
Company
Organic
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Caution: Other
Trader Joe's
products contain
non-organic soy
protein
ingredients,
likely hexaneextracted
Caution: Other
Trader Joe's
products contain
non-organic soy
protein
ingredients,
likely hexaneextracted

Public
Vegetarian Sloppy Joe,
Corporation
Fantastic
Not
Vegetarian Chili, Taco Filling (United
World Foods
Organic
Mix
Natural
Foods)

Franklin
Farms

Veggidogs, Veggiballs,
Veggiburgers and Chick'n
Nuggets

Independent Not
Company
Organic

Gardein

Vegetarian entrees

Independent Not
Company
Organic

Burgers (Black Bean Chipotle,
California Burger, Classic,
Public
Flame Grilled, Portabello and
Not
Gardenburger
Corporation
Veggie Medley), Breakfast
Organic
(Kellogg's)
Sausage and Herb Crusted
Cutlet
Health is
Wealth

Vegan meat alternatives

Independent Not
Company
Organic

Lightlife

Tofu Pups, "Smart" Meat
Public
Not
Alternatives, Gimme Lean and Corporation
Organic
Burgers
(ConAgra)

Veggie Patties, Burgers,
Public
Morningstar Chick'n, Buffalo Wings, Meal
Not
Corporation
Farms
Startes, Veggie Bites, Veggie
Organic
(Kellogg's)
Cakes, Dogs

Soy Boy

Independent
Okara Courage Burgers, Tofu
Company
Not
Breakfast Links, Not Dogs and
(Northern
Organic
Vegetarian Franks
Soy)

Spice of Life Meatless Meats

Independent Not
Company
Organic
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StarLite
Cuisine

Soy Tacos and Soy Taquitos

Independent Not
Company
Organic

Trader Joe's Chicken-Less and Beef-Less

Independent Not
Company
Organic

Vegetarian
Plus

Vegetarian Chicken,
Vegetarian Fish Fillets,
Vegetarian Black Pepper
Steaks, Vegetarian Lamb

Independent
Not
Company
Organic
(VegeUSA)

Independent
Veggie Dogs, Veggie Sausage,
Company
Not
Veggie Patch Veggie Meatballs and Meatless
(Food Tech Organic
Burgers
International)

Whole Foods
Meatless Breakfast Sausage,
(Whole
deli bar's meat alternatives
Kitchen)

Public
Corporation Not
(Whole Foods Organic
Market)

Yves Veggie
Cuisine

Public
Corporation
Not
(The Hain
Organic
Celestial
Group)

Burgers, Meat Alternatives,
Entrees

The guides are based primarily on information acquired through exchanges with industry participants.
Cornucopia staff members contacted companies that produce and market meat alternatives and nutrition
bars, to ask them about their production practices. Every company listed was given the opportunity to
share the details of their production processes with Cornucopia researchers (at a minimum, every
company received a certified letter). Products are listed as containing "Hexane-Extracted Soy Protein"
only when all three criteria are met:
1. The product is not certified organic. Beware products with the claim "made with organic
ingredients" are not certified organic, and do not display the “USDA Organic” seal. These may
contain hexane-extracted protein ingredients.
2. The product contains soy protein ingredients that are nearly universally processed with hexane,
such as soy protein isolate and soy protein concentrate.
3. The product's manufacturer or marketer did not respond to our inquiries regarding the use of
solvents such as hexane in their processing and make no statements or representations on their
packaging or website about going to the expense of procuring organic or conventional nonhexane-extracted soy protein ingredients.
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